SAM
EW icon

Storebrand Asset Management’s Edwards Lifesciences EW Stock Holding History

Storebrand Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.7M Buy
416,442
+20,131
+5% +$1.69M 0.09% 193
2026
Q1 		$31.7M Sell
396,311
-15,621
-4% -$1.29M 0.09% 210
2025
Q4 		$35.1M Buy
411,932
+16,288
+4% +$1.34M 0.09% 189
2025
Q3 		$30.8M Buy
395,644
+6,860
+2% +$536K 0.08% 223
2025
Q2 		$30.4M Buy
388,784
+78,526
+25% +$5.86M 0.09% 211
2025
Q1 		$22.5M Buy
310,258
+26,497
+9% +$1.9M 0.07% 249
2024
Q4 		$21M Buy
283,761
+12,515
+5% +$876K 0.06% 275
2024
Q3 		$17.9M Sell
271,246
-1,716,945
-86% -$125M 0.06% 306
2024
Q2 		$184M Sell
1,988,191
-11,609
-0.6% -$1.03M 0.61% 25
2024
Q1 		$191M Buy
1,999,800
+28,731
+1% +$2.41M 0.65% 24
2023
Q4 		$150M Buy
1,971,069
+1,686,200
+592% +$117M 0.54% 35
2023
Q3 		$19.7M Sell
284,869
-46,087
-14% -$3.7M 0.09% 248
2023
Q2 		$31.2M Buy
330,956
+15,783
+5% +$1.37M 0.14% 171
2023
Q1 		$26.1M Buy
315,173
+3,194
+1% +$251K 0.13% 195
2022
Q4 		$23.3M Sell
311,979
-2,858
-0.9% -$220K 0.13% 206
2022
Q3 		$26M Buy
314,837
+2,000
+0.6% +$192K 0.16% 163
2022
Q2 		$29.7M Sell
312,837
-9,923
-3% -$1.03M 0.17% 149
2022
Q1 		$38M Sell
322,760
-1,940
-0.6% -$218K 0.18% 134
2021
Q4 		$42.1M Sell
324,700
-58,742
-15% -$6.85M 0.19% 130
2021
Q3 		$43.4M Buy
383,442
+66,955
+21% +$7.64M 0.21% 112
2021
Q2 		$32.8M Sell
316,487
-6,399
-2% -$603K 0.16% 152
2021
Q1 		$27M Buy
322,886
+1,255
+0.4% +$106K 0.14% 171
2020
Q4 		$29.3M Buy
321,631
+14,960
+5% +$1.24M 0.17% 139
2020
Q3 		$24.5M Sell
306,671
-676
-0.2% -$52.7K 0.18% 132
2020
Q2 		$21.2M Sell
307,347
-13,488
-4% -$959K 0.18% 134
2020
Q1 		$20.2M Buy
+320,835
New +$23.1M 0.21% 111

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Storebrand Asset Management's EW Position: Q2 2026 in Review

Storebrand Asset Management increased its Edwards Lifesciences (EW) stake by 5.1% in Q2 2026, buying an estimated $1.69M and bringing the position to 416,442 shares worth $37.7M. The position accounts for 0.09% of the portfolio, ranked #193.

Storebrand Asset Management first reported a position in EW in Q1 2020 and has held it in 26 quarters since. The position peaked at $191M in Q1 2024. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Storebrand Asset Management held 416,442 shares of Edwards Lifesciences worth $37.7M as of Q2 2026.
  • Storebrand Asset Management bought 20,131 Edwards Lifesciences shares in Q2 2026, an estimated $1.69M.
  • Edwards Lifesciences made up 0.09% of Storebrand Asset Management's portfolio in Q2 2026, its #193 holding.
  • Storebrand Asset Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Edwards Lifesciences position peaked at $191M in Q1 2024.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.